Warehouse Robot Maker Symbotic Gets Juiced

by | Jun 8, 2022

SYM joins the high redemption/thin float club. Merger approval for DYNS/ Senti Bio. And the rest of the day’s news in SPACs.

————————————————-
Free Investor Resources from Boardroom Alpha
—————————————————-
** Podcast: Know Who Drives Return
** Daily SPAC Newsletter
** Full SPAC Listing

Symbotic Debuts Today

AI-enabled robotics specialist and Walmart-backed Symbotic (SYM) deSPACs today from SVF Investment Corp. 3, sponsored by an affiliate of Japan’s SoftBank. An arb trade favorite, the high redemption /thin float combination had shares popping 120% today to close at $20.07.

DYNS / Senti Bio Approved

Dynamics Special Purpose Corp. (DYNS) approves merger with gene therapy specialist Senti Bio. 14,549,537 shares redeemed (~63%).

SPACs with Announced Transaction Heat Map

Source: Boardroom Alpha

SPAC Calendar

Source: Boardroom Alpha

More from Boardroom Alpha

For ongoing tracking, analytics, and data on SPACs checkout Boardroom Alpha’s SPAC Data and Analytics service.

Recent Analysis

Daily SPAC Update – October 1, 2024

Trailblazer (TBMC) and Learn CW (LCW) Shareholders Approve Extension and Deal. NPAB and LATG Set Extension Votes. BCSA Deal Termination. DSAQ and SLAMF Amend Mergers.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.